Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to use the funds to drive toward profitability next year and continue expanding ...

Adding the firm's multi-cancer early detection test to standard-of-care screening demonstrated substantially greater additional cancer detection than in Pathfinder.

The firm said in May it was considering the surcharge following disclosure of a $40 million tariff-related headwind for 2025.

The shares are expected to begin trading on June 18 under the ticker symbol CAI, and the offering is expected to close on June 20.